Long COVID and the Microbiome: What the Research Is Suggesting

Long Covid has become one of the defining health challenges of the post-pandemic era. Estimates suggest that at least 400 million people globally are living with symptoms that persist long after their initial SARS-CoV-2 infection — fatigue, brain fog, breathlessness, joint pain, digestive disruption, and more. In many cases, these symptoms persist for years.

Understanding why these symptoms persist — and what can be done about them — has been the focus of intensive research since 2020. One of the most significant findings to emerge from that research is this: the gut microbiome appears to play a central role in both the development and the persistence of Long Covid.

COVID-19 as a Gut Disease

Most people think of Covid-19 as a respiratory illness. And initially, it presents that way. But the virus's reach extends far beyond the lungs — and the gut is one of its primary targets.

SARS-CoV-2 enters cells by binding to ACE2 (angiotensin-converting enzyme 2), a receptor found throughout the body — including abundantly in the lining of the gastrointestinal tract. When the virus binds to ACE2 in gut cells, it damages and depletes this enzyme. The consequences are far-reaching.

ACE2 in the intestine has a specific critical function beyond its hormonal regulatory role: it is responsible for facilitating the absorption of the essential amino acid tryptophan. When ACE2 is depleted, tryptophan absorption is impaired, causing a cascade of downstream effects — reduced serotonin production, disrupted gut motility, altered immune signaling, and a dramatically changed environment for the gut microbiome.

In a study published in Nature, researchers found that persistent disruption of gut ACE2 after Covid-19 contributed to bacterial and fungal overgrowth, reduced microbial diversity, and altered gut permeability. The gut, in other words, becomes the site of ongoing pathological change long after the respiratory phase of infection has resolved.

Gut Dysbiosis in Long Covid — What the Research Shows

Multiple large-scale studies have now documented a consistent pattern: people who develop Long Covid have demonstrably different gut microbiomes than those who recover fully.

A landmark 2021 study published in Gut (BMJ) examined the gut microbiomes of hospitalized Covid-19 patients and found that those who developed persistent symptoms had significantly depleted populations of beneficial bacteria — including Faecalibacterium prausnitzii, Eubacterium rectale, and Bifidobacterium species — alongside elevated levels of opportunistic pathogens. Crucially, this dysbiosis pattern was found even in patients with no gastrointestinal symptoms, suggesting the gut disruption is systemic rather than symptomatic.

Another key finding: the degree of gut dysbiosis at the time of acute infection predicted the likelihood of developing Long Covid. People with a more disrupted baseline microbiome were at significantly higher risk of persistent symptoms — independent of disease severity. This led researchers to propose that gut microbiome status is not merely a consequence of Long Covid, but a contributing cause.

Viral Persistence and the Gut

One of the most striking findings in Long Covid research is that the virus itself — or fragments of its proteins — can persist in gut tissue long after the initial infection. Harvard researchers and others have documented SARS-CoV-2 viral proteins in intestinal biopsies of Long Covid patients for up to two years after their initial illness.

Whether this represents active viral replication or residual viral debris is still being studied. But the clinical significance is clear: these persistent viral remnants drive ongoing inflammatory signaling in the gut, disrupting the local immune environment and perpetuating dysbiosis.

This is why some researchers and clinicians — including Dr. Leo Galland, MD — have proposed that addressing viral eradication from the gut is a critical first step in Long Covid treatment, not simply restoring microbial populations. The two goals are interconnected: a disrupted microbiome allows viral remnants to persist, and viral remnants perpetuate microbiome disruption.

Dr. Leo Galland's Perspective on the Gut-Long Covid Connection

Dr. Leo Galland, MD is a Harvard-educated integrative medicine physician based in New York, a member of the Long Covid Advisory Group of the World Health Network, and a pioneer in studying the relationship between the gut microbiome and complex chronic disease. He has been one of the most prominent clinical voices linking Long Covid to gut dysfunction.

In his comprehensive Long Covid: Prevention and Treatment white paper, Dr. Galland describes an 8-strand "Web of Long Covid" — a framework for understanding how the multiple dysfunctions of Long Covid are interconnected, with ACE2 depletion and mitochondrial stress at the center. Microbial gut dysbiosis is one of the eight primary strands, deeply intertwined with viral persistence, T-cell impairment, and systemic inflammation.

In a presentation to the Long Covid Coalition's 4th Colloquium, "Restoring the Gut-Brain Axis after Covid-19," Dr. Galland emphasized that the gut is not a peripheral consideration in Long Covid — it is central. He notes: "Restoring or creating a healthy gut microbiome is likely to be crucial for full recovery from Long Covid."

Critically, Dr. Galland has specifically highlighted the role of soil-derived probiotics — spore-forming bacteria derived from natural soil environments — as the organisms best suited for the first phase of gut restoration in Long Covid. In his clinical protocol, these are used specifically for viral eradication and healing the intestinal lining, described as a "prelude" to the longer microbiome restoration phase.

Soil-Derived Probiotics and Long Covid Research

The clinical evidence for soil-derived probiotics in Long Covid is early but promising. A placebo-controlled trial examined the effect of soil-derived bacterial organisms on Long Covid patients and found significant improvements in energy levels — one of the most debilitating Long Covid symptoms — in the treated group versus placebo.

The proposed mechanism is consistent with Dr. Galland's framework: soil-derived spore-forming bacteria appear to be particularly effective at clearing viral remnants from gut tissue, reducing local inflammatory signaling, and creating the conditions for beneficial bacterial repopulation. Their spore structure means they survive the full GI transit and germinate exactly where they're needed — unlike conventional fragile probiotic strains that may not survive stomach acid.

While it would be inappropriate to make specific clinical claims about any supplement product in this context, the convergence of the mechanism, the clinical interest from leading Long Covid researchers, and the early trial data makes this one of the most actively watched areas in gut health research.

What This Means If You're Experiencing Post-Viral Symptoms

The gut-Long Covid connection is still being actively researched, and no supplement regimen should substitute for medical care if you are experiencing significant or disabling Long Covid symptoms. However, the research does point toward some practical implications:

• Gut health is not peripheral to Long Covid — it is mechanistically central
• Restoring microbial diversity through diet (high-fiber, fermented foods, plant-based) is consistently recommended by researchers
• Spore-based probiotic supplementation is being actively investigated as a targeted intervention for viral clearance and microbiome restoration
• The sequence matters: supporting viral clearance before microbiome restoration may produce better outcomes than either approach alone

If you are navigating post-viral recovery, we encourage you to read Dr. Galland's full white paper at drgalland.com/longcovid — it is one of the most comprehensive, evidence-based, self-directed resources available for Long Covid patients.